Comparing aroeira to omeprazole for indigestion
Treatments studied
Part of Digestive system clinical trials.
This study tests whether an oral herbal medicine called aroeira helps with indigestion symptoms, comparing it to a commonly used medication (omeprazole). If you have chronic indigestion, you may get relief from one of these treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least one of these problems for at least 3 months, starting more than 6 months ago: nausea, heartburn, upper belly pain, discomfort that changes with eating, or feeling full too quickly.
- You are between the ages of 18 and 80.
- You are willing to use birth control during the study if needed.
- You agree to participate in the study voluntarily.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
This study tests how well omeprazole (a common acid-blocking medicine) works for people with laryngopharyngeal reflux (LPR), a condition where stomach acid irritates the throat. If you have had throat symptoms for more than 8 weeks and are already scheduled for an endoscopy with acid monitoring, you may qualify to see if this medicine helps more than a placebo.
This study tests if the medicine omeprazole, commonly used for acid reflux, changes the bacteria in the gut. It may help doctors understand how this treatment affects people with obesity and reflux, and why some people might benefit more than others.
This trial tests two similar study drugs to see how they compare in terms of safety and how the body processes them. It is for healthy adults who want to help with early-stage medication research.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
Hear when a new Dyspepsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.